Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Matinas BioPharma ( (MTNB) ) just unveiled an announcement.
On March 13, 2025, Eric Ende announced his resignation from the Board of Directors and as Chairman of Matinas BioPharma, effective March 14, 2025, due to other professional commitments. His departure was not due to any disagreement or shift in the company’s direction, indicating stability in the company’s strategic focus and operations.
More about Matinas BioPharma
Matinas BioPharma is a company operating in the biopharmaceutical industry, focusing on the development of innovative therapies and products.
YTD Price Performance: -10.51%
Average Trading Volume: 469,999
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $2.72M
See more insights into MTNB stock on TipRanks’ Stock Analysis page.